According to Biolase 's latest financial reports the company's current EPS (TTM) is -$366.82. In 2022 the company made an earnings per share (EPS) of -$569.04 a decrease over its 2021 EPS that were of -$370.35.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$360.28 | -36.69% |
2022 | -$569.04 | 53.65% |
2021 | -$370.35 | -81.87% |
2020 | -$2,042 | -25.32% |
2019 | -$2,735 | -24.76% |
2018 | -$3,635 | -26.06% |
2017 | -$4,915 | 4.33% |
2016 | -$4,711 | -14.71% |
2015 | -$5,524 | -26.09% |
2014 | -$7,473 | 35.41% |
2013 | -$5,519 | 244.31% |
2012 | -$1,603 | -38.05% |
2011 | -$2,588 | -64.8% |
2010 | -$7,351 | 347.66% |
2009 | -$1,642 | -71.05% |
2008 | -$5,672 | 22.58% |
2007 | -$4,627 | 55% |
2006 | -$2,985 | -74.03% |
2005 | -$11,494 | -22.22% |
2004 | -$14,778 | -208.79% |
2003 | $13,584 | 1720% |
2002 | $746.36 | -171.43% |
2001 | -$1,045 | -65% |
2000 | -$2,985 | -28.57% |
1999 | -$4,180 | -56.92% |
1998 | -$9,703 | 209.52% |
1997 | -$3,135 | 5% |
1996 | -$2,985 |